?
open question
Therapeutic window**: Is there a safe level of MARK inhibition?
Open Question
open
Wiki: mechanisms-mark-tau-phosphorylation-pathway
Therapeutic window**: Is there a safe level of MARK inhibition?
Importance Elo
1500
Field Rank
Rank #1145 in mechanisms
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page mechanisms-mark-tau-phosphorylation-pathway
Secondary Market
No secondary market activity yet.
Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
Real-world safety study of Lecanemab in Japanese AD patients
partial answer for
· experiment · 55%
Tau Propagation Causality Test — Does Tau Spread Drive Neurodegeneration or Is It a Bystander?
partial answer for
· experiment · 48%
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Trials Have Not Succeeded
partial answer for
· experiment · 45%
Experiment Proposal (Crux): What is the evidence that blood-brain barrier (BBB) permeability changes serve as early biomarkers f [60426-210049]
discriminating experiment
· experiment_proposal · 42%
HSP90-Tau Disaggregation Complex Enhancement
bears on question
· hypothesis · 40%
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
Experiment Proposal (Crux): What is the evidence that blood-brain barrier (BBB) permeability changes serve as early biomarkers f [60426-210049]
experiment_proposal | discriminating_experiment
HSP90-Tau Disaggregation Complex Enhancement
hypothesis | bears_on_question
Related Entities
mechanisms
View on SciDEX ↗